by Medical Research Council Credit: CC0 Public Domain Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings. The Platform Randomized Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial is led by the University of Oxford. It is...
by Kathy Keatley Garvey, UC Davis COVID-19 image from Centers for Disease Control and Prevention (CDC). A newly published UC Davis research paper pinpoints what could be “the missing link” in why some COVID-19 patients recover and some don’t. A blood plasma biomarker discovered in hospitalized COVID-19 patients may not only predict the severity of adult respiratory distress...
By JOE PINKSTONE FOR MAILONLINE PUBLISHED: 09:31 EDT, 16 March 2021 | UPDATED: 10:32 EDT, 16 March 2021 From a high fever to a dry cough, coronavirus is known to be associated with a range of unpleasant symptoms. Now, new data shows that for one in five people who catch Covid-19, their only symptom is a skin rash. In a further 17 per...
IMIM (HOSPITAL DEL MAR MEDICAL RESEARCH INSTITUTE) Administering zinc supplements to covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering the worst effects of the disease. These are the findings of a...
by European Society of Cardiology MRI scan of damaged heart. Blue means reduced blood flow, orange is good blood flow. In this figure the inferior part of the heart shows dark blue, so the myocardial blood flow is very reduced and the black and white angiography, which looks directly at the blood vessels, shows that the...
AMERICAN THORACIC SOCIETY IMAGE: POST-SEPSIS MODEL MAY HELP COVID-19 PATIENTS AFTER DISCHARGE. iew more CREDIT: ATS Feb. 10, 2021 – A new paper published online in the Annals of the American Thoracic Society describes a “virtual” recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses. In “Translating Post-Sepsis Care...
Interview conducted by Emily Henderson, B.Sc. Jan 18 2021 Thought Leaders Professor Carl Philpott Academic Surgeon University of East Anglia News-Medical catches up with Professor Carl Philpott about the latest findings regarding COVID-19 and smell loss (anosmia), and how sufferers of smell loss post-infection can be treated. We last interviewed you back in the early...
by Hebrew University of Jerusalem HUJI Prof. Yaakov Nahmias. Credit: David Hanoch In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem’s Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19. The study was presented...
MICHIGAN MEDICINE – UNIVERSITY OF MICHIGAN In the first months after their COVID-19 hospital stay, patients face a high risk of ongoing health problems, trips back to the hospital, and death, a growing number of studies has shown. But the first week and a half may be especially dangerous, according to a new study in JAMAby...
DOE/ARGONNE NATIONAL LABORATORY Research has shown that dexamethasone, a widely available steroid, can significantly reduce the chance of death from COVID-19. However, because of the way dexamethasone is transmitted throughout the body, it may be less effective in patients with diabetes, according to new research performed at the Advanced Photon Source (APS), a U.S. Department...
